Stay updated with breaking news from Jeff Wolf. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scorpius subsidiary to manufacture novel biologic targeting substance use disorderDURHAM, N.C., Jan. 03, 2024 -- NightHawk Biosciences , an integrated contract development and manufacturing...
DURHAM, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE American: NHWK) (“NightHawk” or the “Company”), an integrated contract development and manufacturing organization (CDMO), today announced its Scorpius BioManufacturing
Next phase of multi-million-dollar project to include scaling up cGMP manufacturing for phase 1 trial targeting infectious disease CDMO services attracting considerable interest as...
Management's Discussion and Analysis of Financial Condition and Results of Operations with Retrospective Changes of the 2022 Form 10-K. The following discussion...
It’s the Christmas gift that’s giving — again.